Deutsche Bank
ANRO icon

Deutsche Bank’s Alto Neuroscience ANRO Stock Holding History

Deutsche Bank’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Buy
+26,051
New +$602K ﹤0.01% 2600
2025
Q2 		– Sell
-15,210
Closed -$32.9K – 3764
2025
Q1 		$32.9K Hold
15,210
– – ﹤0.01% 3437
2024
Q4 		$64.3K Buy
15,210
+3,629
+31% +$22.6K ﹤0.01% 3381
2024
Q3 		$132K Buy
+11,581
New +$142K ﹤0.01% 3123

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Deutsche Bank's ANRO Position: Q2 2026 in Review

Deutsche Bank opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 26,051 shares worth $687K. The stake represents ﹤0.01% of the portfolio and ranks #2600 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ANRO as recently as Q1 2025.

Deutsche Bank first reported a position in ANRO in Q3 2024 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Deutsche Bank held 26,051 shares of Alto Neuroscience worth $687K as of Q2 2026.
  • Alto Neuroscience was a new Deutsche Bank position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2600 holding.
  • Deutsche Bank first reported a position in Alto Neuroscience in Q3 2024 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.